Updated follow-up and results of subsequent therapy in the phase III VISTA trial: bortezomib plus melphalan--prednisone versus melphalan--prednisone in newly diagnosed multiple myeloma
Updated follow-up and results of subsequent therapy in the phase III VISTA trial: bortezomib plus melphalan--prednisone versus melphalan--prednisone in newly diagnosed multiple myeloma
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2008
Συγγραφείς:
San Miguel, Jesus F Schlag, Rudolf Khuageva, Nuriet K Dimopoulos, Meletios A Shpilberg, Ofer Kropff, Martin H Spicka, Ivan Petrucci, Maria Teresa Palumbo, Antonio Samoilova, Olga S others
